BDTX Company Profile and Key Details

Q: Who are the executives of BDTX?

Dr. Christopher D. Roberts Ph.D.AdvisorDr. Elizabeth Buck Ph.D.Co-Founder & Chief Scientific OfficerMr. Brent Hatzis-Schoch Esq., J.D.Chief Operating Officer & Gen. CounselMs. Melanie MorrisonChief Devel. OfficerMr. Tai-An Lin Ph.D.Senior Vice President of Translational Science & Discovery BiologyDr. Sergey Yurasov M.D., Ph.D.Chief Medical OfficerDr. Fang Ni Pharm.D.Chief Financial Officer, Principal Financial Officer and Chief Bus. OfficerMs. Elizabeth L. MontgomeryChief People OfficerDr. David M. Epstein Ph.D.Co-Founder, Pres, Chief Executive Officer & DirectorMs. Erika JonesVice President of Fin., Corporation Controller & Principal Accounting Officer

NASDAQ : BDTX

Black Diamond Therapeutics

$2.31

-1.245-35.07%

Open: 3:15 PM

63.99

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Black Diamond Therapeutics, Inc. (BDTX) stock declined over -35.19%, trading at $2.30 on NASDAQ, down from the previous close of $3.55. The stock opened at $3.01, fluctuating between $2.28 and $3.07 in the recent session.

Stock Snapshot

3.55

Prev. Close

131.83M

Market Cap

2.28

Day Low

-2.99

P/E Ratio

-0.77

EPS (TTM)

-1.29

Cash Flow per Share

3.01

Open

57.3M

Number of Shares

3.0742

Day High

68.91%

Free Float in %

2.26

Book Value

2.68M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 21, 2026	3.53	3.90	3.48	3.55	5.07M
May 20, 2026	2.96	3.97	2.96	3.60	7.93M
May 19, 2026	2.59	3.02	2.50	3.00	1.87M
May 18, 2026	2.76	2.79	2.55	2.58	678.5K
May 15, 2026	2.82	2.84	2.70	2.75	625.17K
May 14, 2026	2.88	2.96	2.79	2.86	576.72K
May 13, 2026	2.82	2.87	2.80	2.86	502.85K
May 12, 2026	2.93	2.93	2.73	2.83	662.14K
May 11, 2026	3.04	3.18	2.92	2.94	1.23M
May 08, 2026	2.72	3.15	2.70	2.99	1.66M
May 07, 2026	2.77	2.79	2.43	2.72	1.91M
May 06, 2026	2.93	2.97	2.82	2.82	993.1K
May 05, 2026	2.74	2.88	2.71	2.87	863.21K
May 04, 2026	2.60	2.77	2.58	2.70	810.91K
Apr 30, 2026	2.60	2.67	2.55	2.65	569.31K
Apr 29, 2026	2.74	2.74	2.55	2.57	539.8K
Apr 28, 2026	2.90	2.94	2.69	2.70	695.16K
Apr 27, 2026	2.97	3.08	2.87	2.92	683.63K
Apr 23, 2026	3.35	3.43	3.05	3.10	1.05M
Apr 22, 2026	3.20	3.41	3.19	3.35	1.17M

Contact Details

Cambridge, MA 02142

United States

https://www.blackdiamondtherapeutics.com 617 252 0848

About Company

Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penetrant inhibitor of EGFR mutations, including canonical, intrinsic resistance, and acquired resistance mutations; and BDTX-4933, a brain-penetrant inhibitor of oncogenic BRAF class I, II and III alterations. It has a strategic partnership with OpenEye Scientific Software, Inc. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Stock Peers

ARGX

11.97+1.49%

argenx SE$816.22 REGN

-7.17-1.10%

Regeneron Pharmaceuticals, Inc.$642.59 UTHR

1.94+0.34%

United Therapeutics Corporation$565.87 MDGL

0.12+0.02%

Madrigal Pharmaceuticals, Inc.$513.59 VRTX

3.1+0.72%

Vertex Pharmaceuticals Incorporated$433.54 PRAX

14.95+4.45%

Praxis Precision Medicines, Inc.$350.56 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 KRYS

2.18+0.72%

Krystal Biotech, Inc.$304.23 ALNY

2.03+0.68%

Alnylam Pharmaceuticals, Inc.$300.51 ASND

6.17+2.56%

Ascendis Pharma A/S$247.51

Frequently Asked Questions

What is the current Black Diamond Therapeutics, Inc. (BDTX) stock price?

Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) stock price is $2.30 in the last trading session. During the trading session, BDTX stock reached the peak price of $3.07 while $2.28 was the lowest point it dropped to. The percentage change in BDTX stock occurred in the recent session was -35.19% while the dollar amount for the price change in BDTX stock was - $1.25.

BDTX's industry and sector of operation?

The NASDAQ listed BDTX is part of Biotechnology industry that operates in the broader Healthcare sector. Black Diamond Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BDTX?

Dr. Christopher D. Roberts Ph.D.
Advisor
Dr. Elizabeth Buck Ph.D.
Co-Founder & Chief Scientific Officer
Mr. Brent Hatzis-Schoch Esq., J.D.
Chief Operating Officer & Gen. Counsel
Ms. Melanie Morrison
Chief Devel. Officer
Mr. Tai-An Lin Ph.D.
Senior Vice President of Translational Science & Discovery Biology
Dr. Sergey Yurasov M.D., Ph.D.
Chief Medical Officer
Dr. Fang Ni Pharm.D.
Chief Financial Officer, Principal Financial Officer and Chief Bus. Officer
Ms. Elizabeth L. Montgomery
Chief People Officer
Dr. David M. Epstein Ph.D.
Co-Founder, Pres, Chief Executive Officer & Director
Ms. Erika Jones
Vice President of Fin., Corporation Controller & Principal Accounting Officer

How BDTX did perform over past 52-week?

BDTX's closing price is 83.94% higher than its 52-week low of $1.93 where as its distance from 52-week high of $4.94 is -28.14%.

How many employees does BDTX have?

Number of BDTX employees currently stands at 24.

Link for BDTX official website?

Official Website of BDTX is: https://www.blackdiamondtherapeutics.com

How do I contact BDTX?

BDTX could be contacted at phone 617 252 0848 and can also be accessed through its website. BDTX operates from One Main Street, Cambridge, MA 02142, United States.

How many shares of BDTX are traded daily?

BDTX stock volume for the day was 2.68M shares. The average number of BDTX shares traded daily for last 3 months was 967.55K.

What is the market cap of BDTX currently?

The market value of BDTX currently stands at $131.83M with its latest stock price at $2.30 and 57.3M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	24
Beta	3.43
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	24
Beta	3.43
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

BDTX Company Profile and Key Details

Black Diamond Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Company Overview

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Price Forecast & Outlook

Key Takeaways

Valuation Metrics